By applying the technology created by Baker's team, Cyrus scientists are solving some of the biggest challenges of protein drugs, while also developing our own algorithms and new datasets in-house and with the Openfold AI consortium that Cyrus... https://t.co/Hr2jerjSmM
We are mourning the loss of Dan Tawfik, a brilliant researcher and longtime friend of the institute. His scientific accomplishments will endure, as will his kindness, generosity, and humor. Dan made the world a better place.
For celiac patients attempting to maintain a gluten-free diet but who may accidentally ingest gluten, KumaMax has the potential to degrade immune-reactive parts of #gluten. Learn more about our novel approach: https://t.co/BgMR9aTfQm #celiacdisease#drugdevelopment